HDAC9 and pulmonary fibrosis: Huang et al. reported decreased histone acetylation and increased H3K9Me3 at the FAS promoter in patients with idiopathic pulmonary fibrosis, where treatment with histone deacetylase (HDAC) inhibitors restored FAS expression [45].